Related Experiment Video
Updated: Feb 15, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
The national incidence of PML in Sweden, 1988-2013
Ellen Iacobaeus1, Sarah Burkill2, Shahram Bahmanyar2
1From the Department of Clinical Neuroscience, Division of Neurology (E.I., R.H., T.O., L.B.), Neuroimmunology Unit, Center for Molecular Medicine, Department of Clinical Neuroscience (T.O., L.B.), and Center for Pharmacoepidemiology (S. Burkill, S. Bahmanyar, C.B.) and Clinical Epidemiology Unit (M.F., S.M.), Department of Medicine, Solna, Karolinska Institutet, Stockholm; Clinical Epidemiology and Biostatistics (S.M.), School of Medical Sciences, Örebro University, Sweden; and Department of Epidemiology and Public Health (S.M.), University College London, UK. Ellen.Iacobaeus@karolinska.se.
Objective:
To investigate the incidence of progressive multifocal leukoencephalopathy (PML) and patient characteristics in Sweden between 1988 and 2013.
Methods:
All PML diagnoses in Sweden between 1988 and 2013 were identified in the National Patient Register. Information to validate the diagnosis and patient characteristics was obtained from medical records.
Results:
Medical record review classified 108 out of 250 patients (43%) as definite (n = 84), probable (n = 4), or possible (n = 20) PML according to diagnostic criteria. Accurate diagnoses were more common in records obtained from neurology departments (82% of patients seen in neurology departments) compared with other departments (31%) (p < 0.001). The incidence of PML increased from a largely stable level at 0.026 (95% confidence interval [CI] 0.021-0.031) per 100,000 individuals per year during 1988-2010 to 0.11 (95% CI 083-0.137) during 2011-2013, during which time there was a notable increase (p < 0.001). Hematologic malignancies (n = 34), HIV/AIDS (n = 33), and autoimmune disease (n = 23) were the most common underlying diseases. Treatment with a monoclonal antibody prior to PML diagnosis was identified in 26 patients.
Conclusion:
An increased incidence of PML in Sweden was observed and coincided with the prior use of monoclonal antibody treatment. The high level of misdiagnosis emphasizes the importance of immediate contact with a neurology center upon suspicion of PML.
Insights
The incidence of progressive multifocal leukoencephalopathy (PML) in Sweden increased significantly from 2011-2013, coinciding with monoclonal antibody use. Accurate PML diagnosis is crucial and more common in neurology departments.
Area of Science:
- Neurology
- Epidemiology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic demyelinating disease of the central nervous system.
- PML is primarily associated with the JC virus and occurs in immunocompromised individuals.
Purpose of the Study:
- To determine the incidence and patient characteristics of PML in Sweden from 1988 to 2013.
- To investigate potential associations between PML incidence and specific patient factors or treatments.
Main Methods:
- A nationwide population-based study using the Swedish National Patient Register.
- Inclusion of all PML diagnoses between 1988 and 2013, with validation through medical record review.
- Analysis of patient demographics, underlying conditions, and prior treatments.
Main Results:
- Of 250 identified cases, 108 were confirmed as definite, probable, or possible PML.
- PML incidence rose from 0.026 per 100,000 individuals (1988-2010) to 0.11 per 100,000 (2011-2013).
- Common underlying conditions included hematologic malignancies, HIV/AIDS, and autoimmune diseases; 26 patients had prior monoclonal antibody treatment.
Conclusions:
- An increased incidence of PML in Sweden was observed, correlating with prior monoclonal antibody use.
- Accurate PML diagnosis was significantly higher in neurology departments, highlighting the need for specialized care.
- Prompt neurological consultation is vital for suspected PML cases due to diagnostic challenges.
More Related Videos
06:05Using Neutron Spin Echo Resolved Grazing Incidence Scattering to Investigate Organic Solar Cell Materials
Published on: January 15, 2014
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
National Nursing Organizations I
National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Sustainable Development
What is Conservation Biology?